Related Experiment Video
Updated: Jul 14, 2025

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
Machine learning models for predicting the risk factor of carotid plaque in cardiovascular disease
Chengling Bin1, Qin Li1, Jing Tang1
1Health Management Section, The First People's Hospital of Neijiang, Neijiang, China.
Insights
Machine learning effectively predicts carotid plaque risk, a key indicator of cardiovascular disease (CVD). XGBoost showed the best performance, identifying age, smoking, alcohol, and BMI as significant risk factors for early CVD prevention.
Area of Science:
- Cardiology
- Medical Informatics
- Machine Learning
Background:
- Cardiovascular disease (CVD) is a major global health concern.
- Carotid plaque is a significant risk factor for CVD, indicating atherosclerosis severity.
- Early prediction of carotid plaque is crucial for CVD prevention and management.
Purpose of the Study:
- To develop and compare machine learning algorithms for predicting carotid plaque risk.
- To identify key predictors of carotid plaque formation.
- To assess the feasibility of using machine learning in routine CVD management.
Main Methods:
- Eight machine learning algorithms were trained and validated on physical examination data from 4,659 patients.
- 10-fold cross-validation was used for model optimization.
- Shapley Additive Explanations (SHAP) was employed for feature importance analysis.
- Model performance was evaluated using AUC, accuracy, and specificity.
Main Results:
- The XGBoost algorithm demonstrated superior performance with an AUC of 0.808, accuracy of 0.749, and specificity of 0.762.
- Key predictors identified for carotid plaque formation include age, smoking, alcohol consumption, and Body Mass Index (BMI).
- Machine learning models are feasible for predicting carotid plaque risk.
Conclusions:
- The developed machine learning models can be integrated into chronic disease management.
- This enables proactive screening for carotid plaque, potentially improving CVD patient outcomes.
- Machine learning offers a valuable tool for early CVD risk assessment and prevention.
Introduction:
Cardiovascular disease (CVD) is a group of diseases involving the heart or blood vessels and represents a leading cause of death and disability worldwide. Carotid plaque is an important risk factor for CVD that can reflect the severity of atherosclerosis. Accordingly, developing a prediction model for carotid plaque formation is essential to assist in the early prevention and management of CVD.
Methods:
In this study, eight machine learning algorithms were established, and their performance in predicting carotid plaque risk was compared. Physical examination data were collected from 4,659 patients and used for model training and validation. The eight predictive models based on machine learning algorithms were optimized using the above dataset and 10-fold cross-validation. The Shapley Additive Explanations (SHAP) tool was used to compute and visualize feature importance. Then, the performance of the models was evaluated according to the area under the receiver operating characteristic curve (AUC), feature importance, accuracy and specificity.
Results:
The experimental results indicated that the XGBoost algorithm outperformed the other machine learning algorithms, with an AUC, accuracy and specificity of 0.808, 0.749 and 0.762, respectively. Moreover, age, smoke, alcohol drink and BMI were the top four predictors of carotid plaque formation. It is feasible to predict carotid plaque risk using machine learning algorithms.
Conclusions:
This study indicates that our models can be applied to routine chronic disease management procedures to enable more preemptive, broad-based screening for carotid plaque and improve the prognosis of CVD patients.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

